Record Not Found Please inform us and try later.
|
|
|
|
|
|
|
Major Stock Holders
(Prior To
Offering) |
Name |
Class A |
|
Daniel Zurr, Ph.D |
0 |
13.00 |
0 |
0 |
0 |
0 |
|
Philip B. Simon |
0 |
42.50 |
0 |
0 |
0 |
0 |
|
Steven Fink |
0 |
42.30 |
0 |
0 |
0 |
0 |
|
Tako Ventures, LLC |
0 |
42.30 |
0 |
0 |
0 |
0 |
|
Trans-Science Global Bio-Technology Fund |
0 |
9.60 |
0 |
0 |
0 |
0 |
|
|
|
|
Major Stock Holders
(After Offering) |
Name |
Common Stock |
Class A |
Class B |
Class C |
Class L |
ADS |
|
Daniel Zurr, Ph.D |
0 |
9.50 |
0 |
0 |
0 |
0 |
|
Philip B. Simon |
0 |
30.90 |
0 |
0 |
0 |
0 |
|
Steven Fink |
0 |
30.70 |
0 |
0 |
0 |
0 |
|
Tako Ventures, LLC |
0 |
30.70 |
0 |
0 |
0 |
0 |
|
Trans-Science Global Bio-Technology Fund |
0 |
7.00 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Data (Thousand $ Except EPS) |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 2004
|
4,871 |
21,374 |
-16,503 |
0.00 |
-16,233 |
-5.95 |
| 2005
|
3,438 |
11,273 |
-7,835 |
0.00 |
-7,458 |
-2.91 |
| 2006
|
4,252 |
21,862 |
-17,610 |
0.00 |
-16,959 |
-6.21 |
| 2007
|
14,464 |
7,247 |
7,217 |
0.00 |
7,465 |
0.12 |
|
|
|
Balance Sheet Data
(Thousand $) |
Year |
Cash |
Acct Recv. |
Inventory |
Total Cur Assets |
Total Cur Liability |
PPE |
Total Assets |
LT Debt |
SH Equity |
|
2005 |
18,326 |
0.00 |
0.00 |
18,437 |
2,900 |
1,694 |
21,430 |
0.00 |
17,185 |
|
2006 |
19,842 |
647 |
0.00 |
21,362 |
16,725 |
802 |
22,892 |
0.00 |
5,410 |
|
2007 |
26,793 |
935 |
0.00 |
28,965 |
16,667 |
712 |
30,451 |
0.00 |
13,239 |
|
|
|
| Cash
Flow Summary
(Thousand $) |
Year |
Net Cash-Ops |
Net Cash-Inv |
Net Cash-Fin |
Net Change |
|
2004 |
-13,514 |
1,623 |
0.00 |
-11,891 |
|
2005 |
-6,949 |
364 |
10,362 |
3,777 |
|
2006 |
-3,321 |
378 |
4,459 |
1,516 |
|
2007 |
6,988 |
-61 |
24 |
6,951 |
|
|
| |
|
| |
|
|